Susquehanna International Group’s Inozyme Pharma INZY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $900K | Buy |
224,981
+118,107
| +111% | +$472K | ﹤0.01% | 3421 |
|
|
2025
Q1 | $97.3K | Buy |
106,874
+45,824
| +75% | +$41.7K | ﹤0.01% | 5867 |
|
|
2024
Q4 | $169K | Buy |
+61,050
| New | +$169K | ﹤0.01% | 5418 |
|
|
2024
Q3 | – | Sell |
-14,114
| Closed | -$62.9K | – | 6064 |
|
|
2024
Q2 | $62.9K | Sell |
14,114
-16,040
| -53% | -$71.5K | ﹤0.01% | 5236 |
|
|
2024
Q1 | $231K | Sell |
30,154
-13,503
| -31% | -$103K | ﹤0.01% | 4520 |
|
|
2023
Q4 | $186K | Buy |
+43,657
| New | +$186K | ﹤0.01% | 5044 |
|
|
2023
Q3 | – | Sell |
-16,404
| Closed | -$91.4K | – | 5935 |
|
|
2023
Q2 | $91.4K | Buy |
+16,404
| New | +$91.4K | ﹤0.01% | 5033 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 6345 |
|
|
2021
Q2 | – | Sell |
-17,091
| Closed | -$338K | – | 5618 |
|
|
2021
Q1 | $338K | Buy |
+17,091
| New | +$338K | ﹤0.01% | 4242 |
|
|
2020
Q4 | – | Sell |
-8,469
| Closed | -$223K | – | 5027 |
|
|
2020
Q3 | $223K | Buy |
+8,469
| New | +$223K | ﹤0.01% | 3815 |
|